You are now leaving this website. By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co Inc, Rahway, NJ USA.
You are now leaving this website. By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co., Inc., Rahway, NJ, USA.
MSD Ireland’s Animal Health team is committed to the science of healthier animals
Based in Red Oak, Leopardstown, Dublin, MSD Animal Health is a leading veterinary pharmaceutical supplier to customers in both the Republic of Ireland and Northern Ireland, providing a full range of vaccines and pharmaceutical products for cattle, sheep, pigs, dogs, cats, horses, poultry and aquaculture.
We care for our planet and the life it supports
We are determined to build upon our fundamental research strengths to deliver innovation to patients and physicians worldwide, expanding our legacy of invention every day, providing biomedical leadership in pharmaceutical R&D to address unmet needs and the best external science.
We are looking for talented team members and that could be you
Our fast-growing team of talented animal healthcare specialists seek to drive constant improvement in veterinary products and deliver results that inspire betterment in the industry.
This site has been a vibrant part of the pharmaceutical sector in Cork for over 35 years. With a successful legacy of developing and commercially supplying biotech products, Brinny is now specialising in the development and manufacture of innovative novel vaccines and testing of immuno-oncology medicines.
Opened in 1976 and currently employs 500 highly skilled people. The site has API and Formulation facilities for the manufacture and the development of new products. Work relating to 20 of MSD’s pipeline products is undertaken at this state-of-the-art research and commercialisation facility.
Opened in 2008 as MSD’s first vaccines facility outside of the US. Carlow is the filling site for the liquid form of our immuno-oncology treatment for the global market. We are currently working on the construction of a second manufacturing facility that will focus on the production of vaccines and biologics.
This site will play a pivotal role in the manufacture of MSD’s biologics-based medicines, including in the area of immuno-oncology, and will expand MSD’s current internal network of biologics drug substance manufacturing plants when full manufacturing operations begin in 2021.
The latest addition to the MSD, Ireland family is Dunboyne which joined our network in September 2020. With a team of over 200, this site will be MSD’s first Biologics Drug Substance single use commercialization facility, playing an important role in helping us commercialise key medicines.
This careers website is intended for Residents of Europe, Middle East, Africa, Latin America & Asia Pacific. Residents in the United States, Canada & Puerto Rico, please visit this Careers website. Information on this site is for the purpose of presenting career opportunities at our organisation and give our audience a view of our culture, diversity and growth opportunities. Our Company is an equal opportunity employer, proudly embracing diversity in all of its manifestations.